OptimizeRx Corporation (OPRX)
Healthcare • Health Information Services
StockNasdaqCMUnited StatesUS68401U2042
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by OptimizeRx Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:36. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Nov 2026 16:00 | 0.16 | 0.20 | +23.5% | Beat |
| 05 Mar 2026 16:00 | 0.22 | 0.51 | +127.4% | Beat |
| 06 Nov 2025 16:00 | 0.04 | 0.20 | +438.5% | Beat |
| 07 Aug 2025 16:00 | 0.02 | 0.24 | +1,300.2% | Beat |
| 12 May 2025 16:00 | -0.12 | 0.08 | +166.7% | Beat |
| 12 Mar 2025 07:00 | 0.27 | 0.30 | +10.6% | Beat |
| 13 Nov 2024 16:00 | 0.06 | 0.12 | +103.4% | Beat |
| 08 Aug 2024 16:00 | -0.07 | 0.02 | +127.0% | Beat |
| 14 May 2024 16:00 | -0.10 | -0.11 | -5.8% | Miss |
| 15 Apr 2024 16:00 | 0.27 | 0.26 | -2.4% | Miss |
| 06 Nov 2023 07:00 | 0.04 | 0.09 | +150.0% | Beat |
| 14 Aug 2023 16:00 | -0.02 | -0.01 | +53.3% | Beat |
| 10 May 2023 16:00 | -0.08 | -0.09 | -12.5% | Miss |
| 08 Mar 2023 16:00 | 0.24 | 0.25 | +3.6% | Beat |
| 08 Nov 2022 16:00 | 0.04 | 0.07 | +88.5% | Beat |
| 09 Aug 2022 16:00 | 0.09 | 0.04 | -55.6% | Miss |
| 04 May 2022 16:00 | -0.01 | -0.01 | +16.7% | Beat |
| 24 Feb 2022 16:00 | 0.19 | 0.22 | +18.3% | Beat |
| 09 Nov 2021 16:00 | 0.13 | 0.09 | -31.8% | Miss |
| 04 Aug 2021 16:00 | 0.07 | 0.10 | +38.9% | Beat |
| 06 May 2021 16:00 | 0.01 | 0.03 | +275.0% | Beat |
| 24 Feb 2021 16:00 | 0.16 | 0.16 | +3.2% | Beat |
| 09 Nov 2020 16:00 | 0.04 | 0.06 | +55.8% | Beat |
| 05 Aug 2020 16:00 | -0.03 | 0.02 | +166.7% | Beat |
| 04 May 2020 17:00 | -0.03 | -0.06 | -100.0% | Miss |
| 27 Feb 2020 16:00 | 0.01 | -0.03 | -700.0% | Miss |
| 05 Nov 2019 16:00 | 0.08 | -0.05 | -164.5% | Miss |
| 07 Aug 2019 16:00 | 0.08 | 0.09 | +16.1% | Beat |
| 08 May 2019 16:00 | 0.02 | 0.06 | +166.7% | Beat |
| 26 Feb 2019 16:00 | 0.07 | 0.06 | -18.2% | Miss |
| 05 Nov 2018 16:00 | 0.06 | 0.07 | +22.9% | Beat |
| 07 Aug 2018 16:00 | 0.03 | 0.07 | +166.8% | Beat |
| 02 May 2018 16:00 | -0.03 | 0.03 | +204.9% | Beat |
| 27 Feb 2018 16:00 | -0.03 | 0.02 | +157.0% | Beat |
| 02 Nov 2017 16:00 | -0.03 | -0.04 | -43.0% | Miss |
| 08 Aug 2016 16:00 | -0.03 | -0.03 | 0.0% | In line |
| 09 May 2016 16:00 | -0.09 | -0.03 | +66.7% | Beat |
| 15 Mar 2016 16:00 | 0.03 | -0.03 | -200.0% | Miss |
| 12 Nov 2015 16:00 | 0.03 | 0.03 | 0.0% | In line |
| 11 Aug 2015 16:00 | — | 0.03 | — | — |
| 14 May 2015 06:00 | -0.01 | — | +100.0% | — |
| 31 Mar 2015 06:00 | 0.03 | 0.03 | 0.0% | In line |
| 13 Nov 2014 07:00 | — | — | — | — |
| 15 Aug 2014 09:00 | 0.02 | — | -100.0% | — |
| 31 Mar 2014 12:00 | 0.03 | — | -100.0% | — |
| 14 Nov 2013 12:00 | 0.03 | 0.03 | 0.0% | In line |
| 12 Aug 2013 11:00 | 0.06 | 0.03 | -50.0% | Miss |
| 12 Mar 2013 17:00 | -0.03 | 0.03 | +200.0% | Beat |
| 14 Nov 2012 13:00 | — | -0.03 | — | — |
| 14 Aug 2012 14:00 | -0.09 | -0.03 | +66.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 109.4M | +18.8% | 5.1M | 4.7% | 0.27 | +124.5% | 18.7M |
| 2024 | 92.1M | +28.8% | -20.1M | -21.8% | -1.10 | -6.8% | 4.4M |
| 2023 | 71.5M | +14.5% | -17.6M | -24.6% | -1.03 | -60.9% | -8.1M |
| 2022 | 62.5M | — | -11.4M | -18.3% | -0.64 | — | 10.4M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 8.86 | 9.83 | 6.33 | 7.70 | -12.10% | 2,141,586 | |
| 02 Nov 2026 – 06 Nov 2026 | 9.48 | 9.92 | 8.42 | 8.76 | -6.01% | 816,600 | |
| 26 Oct 2026 – 30 Oct 2026 | 9.15 | 9.47 | 8.93 | 9.32 | +1.86% | 580,900 | |
| 19 Oct 2026 – 23 Oct 2026 | 8.40 | 9.60 | 8.40 | 9.15 | +7.65% | 686,300 | |
| 12 Oct 2026 – 16 Oct 2026 | 8.30 | 8.99 | 8.11 | 8.50 | +2.66% | 628,100 | |
| 05 Oct 2026 – 09 Oct 2026 | 8.60 | 9.18 | 8.20 | 8.28 | -3.38% | 835,100 | |
| 28 Sep 2026 – 02 Oct 2026 | 7.88 | 8.86 | 7.69 | 8.57 | +6.59% | 979,900 | |
| 21 Sep 2026 – 25 Sep 2026 | 7.31 | 8.59 | 7.13 | 8.04 | +10.29% | 1,220,700 | |
| 14 Sep 2026 – 18 Sep 2026 | 7.27 | 7.81 | 7.25 | 7.29 | 0.00% | 535,100 | |
| 08 Sep 2026 – 11 Sep 2026 | 7.84 | 7.84 | 6.86 | 7.29 | -7.37% | 401,600 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- OptimizeRx Corp (OPRX) (Q3 2026) Earnings Call Highlights: Margin Expansion and Programmatic ... (opens in a new tab) GuruFocus.com · 12 Nov 2026 15:04
- Stifel Maintains Buy on OptimizeRx, Lowers Price Target to $11 (opens in a new tab) Benzinga · 12 Nov 2026 07:56
- OptimizeRx (OPRX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 12 Nov 2026 06:32
- OptimizeRx Shares Tumble 20% After-Hours: Here's Why (opens in a new tab) Benzinga · 12 Nov 2026 02:01
- What OptimizeRx (OPRX) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 12 Nov 2026 00:13
- OptimizeRx (NASDAQ:OPRX) Shares Fall on Reduced 2026 Revenue Guidance Despite Q3 EPS Beat (opens in a new tab) ChartMill · 11 Nov 2026 23:12
- OptimizeRx Corp. (OPRX) Q3 Earnings and Revenues Beat Estimates (opens in a new tab) Zacks · 11 Nov 2026 21:10
- OptimizeRx Reports Third Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance (opens in a new tab) 11 Nov 2026 21:01
- OptimizeRx Corporation (OPRX) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 20:18
- OptimizeRx Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 11 Nov 2026 18:28
- OptimizeRx Q3 Adj. EPS $0.20 Beats $0.17 Estimate, Sales $21.615M Beat $21.188M Estimate (opens in a new tab) Benzinga · 11 Nov 2026 17:02
- OptimizeRx Lowers FY2026 Sales Guidance from $95.000M-$100.000M to $87.000M-$93.000M vs $96.230M Est (opens in a new tab) Benzinga · 11 Nov 2026 17:01
- Why OptimizeRx Bears Were Right Before A 52% Drop (opens in a new tab) Simply Wall St. · 03 Nov 2026 20:10
- Trade Desk Integration and Programmatic Capabilities Drive OptimizeRx’s (OPRX) Q4 Catalyst (opens in a new tab) Insider Monkey · 22 Oct 2026 14:05
- What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For Shareholders (opens in a new tab) Simply Wall St. · 02 Oct 2026 14:10
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 8.87 USD
- Market cap
- 167.1M
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 1.2 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 14.1 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 10.7 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 37.29× | Weak | 30.56× |
| P/E (forward) | 8.57× | Good | 14.16× |
| Price / book | 1.29× | Good | 3.5× |
| Price / sales | 1.71× | Good | 3.33× |
| EV / EBITDA | 10.54× | Fair | 11.19× |
| Free cash flow yield | 9.3% | Good | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 73.2% | Good | 54.9% |
| Operating margin | 11.4% | Fair | 5.8% |
| Net margin | 4.7% | Weak | 1.2% |
| Return on equity | 3.7% | Weak | 4.4% |
| Return on assets | 4.2% | Fair | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 20.6% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.15× | Good | 0.4× |
| Net debt / EBITDA | -0.3× | Good | 1.46× |
| Interest cover | 2.28× | Weak | 2.17× |
| Current ratio | 5.58× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow OPRX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.